XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
OPERATING EXPENSES        
Research and development $ 1,573,879 $ 1,170,710 $ 3,040,544 $ 2,283,369
General and administrative 610,877 663,284 1,175,803 1,172,985
Total operating expenses 2,184,756 1,833,994 4,216,347 3,456,354
LOSS FROM OPERATIONS (2,184,756) (1,833,994) (4,216,347) (3,456,354)
OTHER INCOME (EXPENSE)        
Interest income 83,134 88,954 182,472 141,516
Interest expense (13,315) (94) (49,808) (938)
Other income (expense), net 69,819 88,860 132,664 140,578
NET LOSS $ (2,114,937) $ (1,745,134) $ (4,083,683) $ (3,315,776)
Net loss/Weighted average common shares        
Net loss per common share- basic $ (0.18) $ (0.15) $ (0.35) $ (0.29)
Net loss per common share- diluted $ (0.18) $ (0.15) $ (0.35) $ (0.29)
Weighted average common shares outstanding - basic 11,745,906 11,610,303 11,732,349 11,601,335
Weighted average common shares outstanding - diluted 11,745,906 11,610,303 11,732,349 11,601,335